Real-World Effectiveness and Optimal Dosage of Favipiravir for Treatment of COVID-19: Results from a Multicenter Observational Study in Thailand

Favipiravir is a broad-spectrum oral antiviral agent that shows in vitro activity against SARS-CoV-2. Presently, data on the real-world effectiveness and optimal dosage of favipiravir for treating COVID-19 are limited. We conducted a retrospective observational study of hospitalized adult patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Rattanaumpawan, Pinyo, Jirajariyavej, Supunnee, Lerdlamyong, Kanokorn, Palavutitotai, Nattawan, Saiyarin, Jatuporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220013/
https://www.ncbi.nlm.nih.gov/pubmed/35740211
http://dx.doi.org/10.3390/antibiotics11060805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220013/
https://www.ncbi.nlm.nih.gov/pubmed/35740211
http://dx.doi.org/10.3390/antibiotics11060805

Ejemplares similares